In particular, considering previous studies on the molecular effects of Metformin, alone or in combination with other therapeutic compounds, in solid tumor cell models and in multiple myeloma cells [28-30], we have first investigated the expression levels of Mcl-1. This evidence concerns the gene MCL1 and plasma cell myeloma.